Patent Assignment
Reel/Frame 016631/0705
Assignment of Assignor's Interest
Recorded: 2005-02-18
Pages: 5
Assignee
SIRNA THERAPEUTICS, INC.
2950 WILDERNESS PLACE, BOULDER, COLORADO, 80301
Covered Property
(1)
RNA interference mediated inhibition of B-cell CLL/Lymphoma-2 (BCL-2) gene expression using short interfering nucleic acid (siNA)
Application:
10/923,516 →
Publication:
US 2005/0176025